跳至主要内容
临床试验/NCT00175227
NCT00175227已完成不适用

Prevention of Contrast-Induced Nephropathy: a Randomized Controlled Trial of Saline + Furosemide + Mannitol in High Risk Patients Undergoing Cardiac Angiography

University of Alberta1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 1996年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Proportion of patients that develop contrast-induced nephropathy after cardiac angiography

研究概览

简要总结

Patients with pre-existing kidney disease are at high risk of acute renal failure when exposed to radio-contrast dyes, for example during a cardiac angiogram.

The investigators hypothesize that an infusion of saline + furosemide + mannitol will reduce rates of contrast-induced nephropathy when compared with saline infusion controls.

详细描述

Patients with pre-existing kidney disease are at high risk of acute renal failure when exposed to radio-contrast dyes, for example during a cardiac angiogram.

We hypothesize that an infusion of saline + furosemide + mannitol will reduce rates of contrast-induced nephropathy when compared with saline infusion controls.

We define an episode of contrast nephropathy using the conventional often published definition of a 25% relative increase in serum creatinine OR a 44 umol absolute increase in serum creatinine within 48 hours of contrast exposure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 21 years
  • serum creatinine > 150 umol/L
  • able and willing to provide informed consent

排除标准

  • known hypersensitivity to contrast, furosemide, or mannitol
  • unable to tolerate a fluid load (e.g., acute pulmonary edema)
  • ESRD, on dialysis
  • previous enrollment in this study or previous contrast administration with the last 2 weeks
  • refusal by treating physician

研究组 & 干预措施

Intervention

Experimental

Saline hydration + mannitol + furosemide

干预措施: intravenous saline hydration + mannitol + furosemide (Drug)

Controls

Placebo Comparator

Saline hydration without mannitol or furosemide

干预措施: intravenous saline hydration (Drug)

结局指标

主要结局

Proportion of patients that develop contrast-induced nephropathy after cardiac angiography

时间窗: Within 48 hours of angiogram

次要结局

  • Safety of the intervention based on transfer to ICU, need for dialysis, or death(During hospitalization episode)
  • Adverse clinical events and measures of renal function(6 weeks post-angiogram)
  • Health related quality of life(6 weeks post-angiogram)
  • Subgroup analyses based on (a) diabetes; (b) amount of contrast; and (c) baseline creatinine(Within 48 hours of angiogram)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Prevention of Contrast-Induced Nephropathy | 临床试验